Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Winer A, Ghatalia P, Bubes N, Anari F, Varshavsky A, Kasireddy V, Liu Y, El-Deiry WS. Winer A, et al. Among authors: varshavsky a. Oncologist. 2019 Nov;24(11):1416-1419. doi: 10.1634/theoncologist.2018-0686. Epub 2019 Aug 23. Oncologist. 2019. PMID: 31444293 Free PMC article.
Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS. Ghatalia P, et al. Among authors: varshavsky a. Front Oncol. 2019 Jan 17;8:652. doi: 10.3389/fonc.2018.00652. eCollection 2018. Front Oncol. 2019. PMID: 30705875 Free PMC article.
Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS. Ghatalia P, et al. Among authors: varshavsky a. Front Oncol. 2021 May 7;11:674782. doi: 10.3389/fonc.2021.674782. eCollection 2021. Front Oncol. 2021. PMID: 34026652 Free PMC article.
Recognition of nonproline N-terminal residues by the Pro/N-degron pathway.
Dong C, Chen SJ, Melnykov A, Weirich S, Sun K, Jeltsch A, Varshavsky A, Min J. Dong C, et al. Among authors: varshavsky a. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14158-14167. doi: 10.1073/pnas.2007085117. Epub 2020 Jun 8. Proc Natl Acad Sci U S A. 2020. PMID: 32513738 Free PMC article.
222 results